North AmericaThe North America immunohistochemistry market is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases such as cancer, and significant investments in research and development. The U.S. leads the regional market due to the adoption of innovative diagnostic tools and a growing focus on precision medicine. Canada also contributes...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian